Business process improvement / strategic planning services
Ended Awarded Last action
- Contract number
- 75F40121F19044
- Awardee
-
Booz Allen Hamilton Inc. UEI JCBMLGPE6Z71 Part of Booz Allen Hamilton Holding Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $248,822
Award facts
- Contract value 100% obligated
- $248,822.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- West McLean, VA 22102, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$754 | |
| Other Administrative Action | $0 | |
| Original award | $249,576 |
About this award
Booz Allen Hamilton Inc. received a contract modification from the Food and Drug Administration valued at $248,822.40 to close out and de-obligate remaining funds on a business process improvement and strategic planning services engagement. The contract was issued as a call against the Mission Oriented Business Integrated Services (MOBIS) blanket purchase agreement and operated under a labor-hour pricing model. The award was made to the McLean, Virginia-based firm without a small business set-aside designation, reflecting Booz Allen Hamilton's status as a large business prime contractor. The contract period spanned from April 13, 2021, to April 13, 2022, with performance conducted in West McLean, Virginia.
This modification represents the final closeout action for a task order supporting FDA's internal business operations and strategic initiatives. Booz Allen Hamilton's engagement with the FDA encompasses a broader portfolio of work across regulatory science optimization, electronic submissions support, and biomarker tracking capabilities. The MOBIS vehicle under which this contract was awarded is a GSA-administered multiple-award schedule that enables federal agencies to procure management, technology, and engineering services efficiently across various mission areas. The de-obligation modification concluded the contractor's obligations under this particular task order while maintaining Booz Allen Hamilton's standing on the FDA's broader contract vehicles for potential future strategic consulting and process improvement initiatives.
Quick answers
Who was awarded contract 75F40121F19044?
75F40121F19044 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on April 13, 2021.
How much is contract 75F40121F19044 worth?
The government has obligated $248,822 on 75F40121F19044.
Is contract 75F40121F19044 an order under another contract?
Yes. 75F40121F19044 is a BPA call under GS23F9755H-HHSF223201510027B, a blanket purchase agreement, on Mission Oriented Business Integrated Services (MOBIS).
Was contract 75F40121F19044 competed?
The extent of competition for 75F40121F19044 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award